HOME >> MEDICINE >> NEWS
Vaccine shows promise for kidney cancer

Results of a phase III study from Germany in this week'ss issue of THE LANCET suggest that a tumour-based vaccine could reduce disease recurrence and increase survival of patients who have had surgery for kidney cancer.

3% of cancer occurs in the kidney, with around 12,000 renal-cancer deaths a year in the USA. Removal of part or all of the kidney (nephrectomy) is the standard treatment for renal cancer, although other treatments after surgery (eg, radiotherapy, chemotherapy) are not effective. Around half of patients with renal cancer will have disease recurrence within 5 years.

Dieter Jocham from the University of Lubeck Medical School, Germany, and colleagues studied 558 patients from 55 medical centres in Germany with a renal tumour scheduled for nephrectomy. Before surgery, all patients were randomised to receive autologous renal tumour cell vaccine (six injections in the upper arm at 4-week intervals after surgery; the vaccine group) or no additional treatment (the control group).

Data were available for 379 patients. 5-year progression-free survival rates were 77% in the vaccine group and 68% in the control group. The vaccine was well tolerated, with only 12 adverse events associated with the treatment. The authors conclude that the vaccine can now be considered for renal cancer patients with tumours larger than 2.5 cm who have undergone nephrectomy.

Referring to Jocham and colleagues' study as an "immunological breakthrough", Mayer Fishman and Scott Antonia from H Lee Moffitt Cancer Center and Research Institute, Tampa, USA, state in an accompanying Commentary (p 583):"[Jocham and colleagues] carefully collected data are part of a broadening base of clinical observations of the potential to affect the biology of a solid tumour with non-toxic readministration of autologous tumour-derived materials. The key milestone is the suggestion of a fixed point-a non-toxic vaccine with a biological clinically relevant ef
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
19-Feb-2004


Page: 1 2

Related medicine news :

1. Vaccine against childhood pneumonia shows promise
2. Vaccine may complement conventional treatment for chronic leukaemia
3. Vaccine preparedness, or not
4. Oct. 14 Web cast: Reporters Workshop -- Covering Vaccines & Immunizations
5. Vaccine reduces racial disparity in incidence of childhood pneumonia and meningitis
6. Vaccine nips breast cancer in the bud
7. Vaccine development against influenza A (h5n1) virus should be made a priority
8. Vaccines against fatal African cattle fever
9. Vaccine development sparks debate on changes to cervical cancer screening guidelines
10. Vaccine shortage study exposes nations patchwork system
11. Vaccines prevent cancers of the liver and cervix

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/23/2019)... ... May 23, 2019 , ... In ... College, Altus Assessments has published new research in an academic journal, Academic Medicine, ... potential of increasing the racial and ethnic diversity of incoming medical students. , ...
(Date:5/23/2019)... SAN JOSE, Calif. (PRWEB) , ... May 23, 2019 , ... ... Rx IP Cores seamlessly integrated with its MIPI C-PHY v.1.2 IP supporting speeds ... per lane) and D-PHY v2.0 supporting speeds of upto 4.5 Gbps data rate per ...
(Date:5/23/2019)... ... 2019 , ... Join Dr. Ashok Srivastava, CEO & CMO at ClinFomatrix and ... at OmniComm Systems, Inc. , in a live webinar on Tuesday, ... benefits of visual patient profiles. Together, the two speakers bring years of experience in ...
(Date:5/23/2019)... Ariz. (PRWEB) , ... May 23, 2019 , ... ... Programs and Potomac Pathways are joining forces to turn the tide in the ... called Potomac Programs and signifies Embark’s commitment to community, outpatient, and home-based care. ...
(Date:5/22/2019)... ... 2019 , ... Impact Advisors , a leading provider of clinical, revenue ... been named to Becker’s Hospital Review’s 150+ Top Places to Work in Healthcare list. ... , “It is a great honor to be named to Becker’s 150+ Top ...
Breaking Medicine News(10 mins):
(Date:5/22/2019)... ... 2019 , ... On Thursday, May 23rd, AT&T’s Xandr will ... from 6-9 pm titled "Finding My Superpower: Stories from the Disability Community." This ... honest perspectives on disability, its unique challenges, and finding one's surprising power. , ...
(Date:5/22/2019)... ... 2019 , ... Americans can save more money on generic drugs at U.S. ... prices on the top-selling generic drugs. Eighty-eight percent of the top prescribed generics were ... lower at Canadian and other international online pharmacies than in the U.S. ...
(Date:5/22/2019)... BEACH, Fla. (PRWEB) , ... May 22, 2019 , ... Vib has announced the release ... to know about CBD vaping for beginners and explains some of the benefits it offers. ... was ‘to quit smoking’ the long-term vaping community is finally realizing that there are lots ...
Breaking Medicine Technology:
Cached News: